Associate Director of Translational Research, Sylvester Pancreatic Cancer Research Institute
Division of Surgical Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Dr. Jash Datta is a hepatobiliary, pancreatic, and gastrointestinal surgical oncologist at the University of Miami Miller School of Medicine. His laboratory in GI cancer immunology focuses on understanding how tumor-intrinsic transcriptional programs orchestrate immune suppression in the pancreatic tumor microenvironment, specifically deciphering and targeting the dominant tolerogenic myeloid cell-derived signaling mechanisms that govern T-cell dysfunction and stromal inflammation. His clinical and translational research interests are in optimizing the physiologic and biologic selection of patients for neoadjuvant therapies in GI cancers, and leveraging the neoadjuvant platform to discover novel predictive biomarkers of therapeutic response and resistance.